Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Motus GI Hldgs

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga · Oct 6, 2022

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Intraday Session

Benzinga · Sep 29, 2022

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga · Aug 3, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stocks That Hit 52-Week Lows On Monday

On Monday, 100 companies reached new 52-week lows.

Benzinga · Jul 25, 2022

HC Wainwright & Co. Maintains Buy Rating for Motus GI Hldgs: Here's What You Need To Know

HC Wainwright & Co. has decided to maintain its Buy rating of Motus GI Hldgs (NASDAQ:MOTS) and lower its price target from $2.00 to $1.50. Shares of Motus GI Hldgs are trading up 2.97% over the last 24 hours, at $0.27 per share.

Benzinga · May 16, 2022

Motus GI Hldgs's Return On Capital Employed Overview

According to data from Benzinga Pro, during Q4, Motus GI Hldgs's (NASDAQ:MOTS) reported sales totaled $99.00 thousand. Despite a 0.12% increase in earnings, the company posted a loss of $4.82 million.

Benzinga · Mar 31, 2022

Earnings Preview: Motus GI Hldgs

Motus GI Hldgs (NASDAQ:MOTS) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Motus GI Hldgs will report an earnings per share (EPS) of $-0.10.

Benzinga · Mar 28, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

1

Coverage From

Benzinga

Organisations

CASI Pharmaceuticals

Avenue rapeutics

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play